uniQure (QURE) Non-Current Deffered Revenue (2015 - 2020)
uniQure (QURE) recorded quarterly Non-Current Deffered Revenue of $22.4 million in Q3 2020, down 2.76% quarter-over-quarter from $23.0 million in Q2 2020, and down 6.15% on a YoY basis from $23.9 million in Q4 2019.
uniQure (QURE) Non-Current Deffered Revenue (2015 - 2020) Analysis & Trends
uniQure's Non-Current Deffered Revenue history runs 6 years deep, the most recent figure standing at $22.4 million for Q3 2020.
- In Q3 2020, Non-Current Deffered Revenue fell 6.15% year-over-year to $22.4 million; the TTM figure through Sep 2020 stood at $22.4 million (down 6.15% YoY), while the FY2019 annual figure was $23.1 million, down 19.83% from the prior year.
- Non-Current Deffered Revenue was $22.4 million for Q3 2020 at uniQure, down from $23.0 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $75.6 million in Q4 2016 to a low of $8.1 million in Q1 2017.
- Historically, Non-Current Deffered Revenue has averaged $27.8 million across 5 years, with a median of $23.8 million in 2019.
- Biggest YoY gain for Non-Current Deffered Revenue was 346.9% in 2018; the steepest drop was 87.98% in 2018.
- A 5-year view of Non-Current Deffered Revenue shows it stood at $75.6 million in 2016, then slumped by 87.95% to $9.1 million in 2017, then jumped by 216.67% to $28.9 million in 2018, then slipped by 19.83% to $23.1 million in 2019, then slipped by 3.13% to $22.4 million in 2020.
- The last three Non-Current Deffered Revenue figures came in at $22.4 million (Q3 2020), $23.0 million (Q2 2020), and $23.7 million (Q1 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 22.41 Mn |
| Jun 30, 2020 | 23.05 Mn |
| Mar 31, 2020 | 23.71 Mn |
| Dec 31, 2019 | 23.14 Mn |
| Sep 30, 2019 | 23.88 Mn |
| Jun 30, 2019 | 26.35 Mn |
| Mar 31, 2019 | 27.47 Mn |
| Dec 31, 2018 | 28.86 Mn |
| Sep 30, 2018 | 8.16 Mn |
| Jun 30, 2018 | 32.85 Mn |
| Mar 31, 2018 | 36.15 Mn |
| Dec 31, 2017 | 9.11 Mn |
| Sep 30, 2017 | 67.86 Mn |
| Jun 30, 2017 | 8.49 Mn |
| Mar 31, 2017 | 8.09 Mn |
| Dec 31, 2016 | 75.61 Mn |
| Dec 31, 2015 | 83.45 Mn |